In commercial Fmoc-based solid-phase peptide synthesis (SPPS), solvent consumption is concentrated in the washes that follow each Fmoc removal, not in the coupling step. Residual piperidine retained in the resin matrix can continue to deprotect Fmoc-amino acid in solution during the subsequent coupling and generate insertion-peptide impurities. Conventional batch protocols therefore apply repeated DMF washes — commonly nine cycles — before the next residue is introduced. Process mass intensity for peptide active pharmaceutical ingredients is frequently estimated at 3,000–15,000 kg of material per kg of product, with solvent as the dominant term. DMF is classified as a substance of very high concern under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation. At the manufacturing scale now required for glucagon-like peptide-1 (GLP-1) receptor agonist analogs, that wash protocol is a process-mass and waste-handling constraint.
EcoQuench reframes the unit operation. The objective of the post-deprotection wash is elimination of piperidine’s chemical activity, not necessarily its physical removal. A Brønsted acid of appropriate strength protonates residual piperidine to piperidinium, which lacks the basicity and nucleophilicity required for further Fmoc cleavage. Completion is defined by effluent pH rather than by a fixed wash count.
Residual base after Fmoc removal
Fmoc deprotection proceeds by base-mediated abstraction of the C9 fluorene proton and β-elimination to dibenzofulvene, which is trapped by excess secondary amine. After drainage of the 20 vol% piperidine/DMF charge, adsorbed piperidine remains in the swollen resin. If that base enters the coupling step, insertion peptides form. These species are structurally and chromatographically similar to the target sequence.
Figure 1. Mechanism of Fmoc deprotection
Requirements for a quench acid
Acidity alone is not a sufficient selection criterion. The quench reagent must reduce wash effluent to pH below 7, must not acylate the resin-bound aliphatic amine, must leave subsequent coupling kinetics intact, and must form a piperidinium salt that remains soluble in DMF so that precipitation does not foul the reactor frit. Aliphatic carboxylic acids meet the pH requirement and fail the selectivity requirement: they cap the N-terminus by amide formation. The candidates that meet all four criteria are N-hydroxyl compounds already used as coupling activators.
Figure 2. Quenching of residual piperidine
| Compound | Structural class | pKa (approx.) | Role in SPPS | Suitability |
|---|---|---|---|---|
| Pentafluorophenol (PFP) | Halogenated phenol | ~5.5 | Activating ester formation | Confirmed |
| 1-Hydroxybenzotriazole (HOBt) | Benzotriazol-1-ol | ~4.6 | Coupling activator with N,N′-diisopropylcarbodiimide (DIC) | Confirmed |
| HOOBt | Hydroxybenzotriazinone | ~4.1 | Low-epimerization activator | Confirmed |
| OxymaPure | Oxyiminoacetate ester | ~4.0 | Low-racemization activator | Confirmed |
| N-Hydroxysuccinimide (NHS) | N-Hydroxysuccinimide | ~6.0 | Active ester synthesis | Confirmed |
| Formic acid | Aliphatic carboxylic acid | ~3.7 | Not used in SPPS | Rejected — caps resin amine |
| Acetic acid | Aliphatic carboxylic acid | ~4.8 | Not used in SPPS | Rejected — same mechanism |
Table 1. Quenching Agent Selection and Characterization. Structural class, approximate pKa, established role in Fmoc-SPPS, and suitability assessment for each candidate Brønsted acid evaluated as a piperidine-quenching agent. Pentafluorophenol, HOBt, HOObt, OxymaPure, and NHS are confirmed suitable: each is sufficiently acidic to protonate piperidine while forming O-acyl rather than N-acyl species, avoiding capping of the resin-bound free amine. Formic acid and acetic acid are rejected despite adequate acidity, as both react directly with the resin-bound amine to form stable N-acyl capping groups, terminating chain elongation.
Cycle sequence
The protocol is a retrofit to existing batch SPPS reactors. Deprotection is unchanged. A short pre-quench DMF wash removes bulk piperidine. The quench wash is then applied until effluent pH is below 7, after which coupling proceeds under standard DIC activation.
| Step | Operation | Parameters |
|---|---|---|
| Deprotection | Treatment of N-Fmoc-protected peptide-resin with 20 vol% piperidine in DMF | 1.0–3.0× resin volume; 5–30 min; 5–45 °C |
| Drain | Removal of deprotection solution by filtration | — |
| Pre-quench wash | DMF wash to remove bulk piperidine | 1–3 washes; 0.5–2.0× resin volume per wash |
| Quench wash | Brønsted acid in DMF; repeated until effluent pH < 7 | 0.5–2.0× resin volume per wash; endpoint pH < 7 |
| Drain | Removal of quench-wash solution | — |
| Coupling | Fmoc-amino acid / activator / DIC | Molar ratio (amino acid:activator:DIC:resin) = 3:3:3:1; 20–30 °C; ninhydrin endpoint |
Table 2. Reagent-Quenching SPPS Process Sequence. Stepwise operations for one deprotection–coupling cycle, from Fmoc removal through quench wash to coupling. The pH <7 quench wash endpoint replaces fixed wash-count criteria with a directly measurable completion parameter.
Experimental scope
Validation comprised three substrates: an 11-residue proline-rich carboxamide (60 mmol), a 5-residue all-D sequence (10 mmol), and a 31-residue lipidated GLP-1 receptor agonist analog (40 mmol). Compatible supports included Wang, 2-chlorotrityl chloride (CTC), and Rink Amide aminomethyl resins. Each quenching condition was compared with a conventional nine-wash control.
Wash-volume and cycle-time reductions, crude high-performance liquid chromatography (HPLC) purity relative to that control, and the validated operating ranges are reported in the white paper.
To download the full white paper, click the button below.
